Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Interviews as Topic × 1 year × Clear all

Phase

Phase NA 88 Phase 2 5 Phase 4 1 Phase 3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neuroblastoma 1 Neoplasms 1

Interventions

pembrolizumab 215 Cyclophosphamide 211 Specimen Handling 172 fludarabine 150 Magnetic Resonance Spectroscopy 146 Biopsy 129 Nivolumab 113 Carboplatin 86 Radiotherapy 84 Paclitaxel 77 venetoclax 75 Gemcitabine 73 fludarabine phosphate 70 Cisplatin 70 Injections 58 Bevacizumab 55 atezolizumab 53 Azacitidine 53 Radiation 52 Ipilimumab 51 Dexamethasone 51 Radiosurgery 50 durvalumab 48 Fluorouracil 46 Cetuximab 46 Docetaxel 45 Temozolomide 44 Rituximab 38 Cytarabine 38 Oxaliplatin 37

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02780128 2026-03-10

NEPENTHE

Children's Hospital of Philadelphia

Phase 1 Terminated

Neoplasms, Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡